Implantation of a Leadless Pacemaker after Incomplete Transvenous Lead Extraction in a 90-Year-Old Pacemaker-Dependent Patient
Gerald Drożdż,
Bruno Hrymniak,
Bartosz Biel,
Przemysław Skoczyński,
Wiktoria Drożdż,
Dorota Zyśko,
Waldemar Banasiak and
Dariusz Jagielski
Additional contact information
Gerald Drożdż: Department of General Internal Medicine, Kantonsspital Graubünden, 7000 Chur, Switzerland
Bruno Hrymniak: Centre for Heart Diseases, Department of Cardiology, 4th Military Hospital, 50-981 Wroclaw, Poland
Bartosz Biel: Centre for Heart Diseases, Department of Cardiology, 4th Military Hospital, 50-981 Wroclaw, Poland
Przemysław Skoczyński: Centre for Heart Diseases, Department of Cardiology, 4th Military Hospital, 50-981 Wroclaw, Poland
Wiktoria Drożdż: Department of General Internal Medicine, Kantonsspital Graubünden, 7000 Chur, Switzerland
Dorota Zyśko: Centre for Heart Diseases, Department of Cardiology, 4th Military Hospital, 50-981 Wroclaw, Poland
Waldemar Banasiak: Centre for Heart Diseases, Department of Cardiology, 4th Military Hospital, 50-981 Wroclaw, Poland
Dariusz Jagielski: Centre for Heart Diseases, Department of Cardiology, 4th Military Hospital, 50-981 Wroclaw, Poland
IJERPH, 2022, vol. 19, issue 10, 1-5
Abstract:
Transluminal lead extraction (TLE) is a well-established procedure for the removal of damaged or infected pacing systems. Despite its high efficacy, the procedure is associated with significant risks, some of which may contribute to severe life-threatening complications. Herein, we present the case of a 90-year-old female who was 100% pacemaker-dependent (PM-dependent) and had ventricular lead fragmentation after the TLE procedure. In this elderly patient, after taking into account the whole clinical context—age, frailty syndrome, infection, and high peri- and postprocedural risks—we decided on MICRA VR implantation as well as leaving the remains of the ventricular lead in the right heart chambers. A Leadless pacemaker (LP) is an excellent alternative to PM-dependent individuals, in whom implantation of permanent transvenous PM is precluded due to multiple infectious and non-infectious issues.
Keywords: transluminal lead extraction; leadless pacemaker; MICRA VR (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.mdpi.com/1660-4601/19/10/6313/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/10/6313/ (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:10:p:6313-:d:821562
Access Statistics for this article
IJERPH is currently edited by Ms. Jenna Liu
More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().